Human liver cancer cells (Hep 3B Luc)

The Human liver cancer cells (Hep 3B Luc) provide a robust platform for cancer research allowing scientists to explore the mechanisms of liver cancer progression and metastasis while facilitating the development of targeted therapies These epithelial adherent cells can be preserved in dry ice for long-term storage ensuring viability during T25 live cell transportation making them an essential resource for studies in oncology and regenerative medicine

In drug discovery Hep 3B-Luc cells are invaluable for screening potential therapeutic compounds as their luminescent marker enables researchers to monitor cell viability and response to treatments in real time The adherence properties of these cells encourage relevant in vitro studies allowing for the evaluation of drug efficacy and toxicity in a controlled environment that mimics the human liver

Additionally the unique attributes of Hep 3B-Luc cells such as their adaptability to various growth conditions and their compatibility with a wide range of culture media (like 87% MEM + 10% FBS + 1% Glutamax etc) empower researchers to optimize growth conditions for specific experimental requirements This flexibility enhances the predictability and relevance of the findings ultimately contributing to advancements in understanding liver cancer and improving patient outcomes